OTCMarketBulls.com Featured Company News: Vivakor Signs Business Development Agreement

Dec. 16, 2009 - PRLog -- has signed a Business Development agreement with Baker Consulting out of Walnut Creek, California and its affiliate group, Kyouko Group, Inc. out of South Florida. Baker Consulting has been retained by Vivakor to assist with business development, financing and assisting the company with its recently reported acquisition strategy. Specifically, Baker Consulting is exploring potential acquisition targets for Vivakor in the areas of ophthalmological devices and treatment solution companies as well as other targets aligned with Vivakor's existing divisions. In addition to vetting and presenting specific opportunities, Baker Consulting is continuing to present financing opportunities for these transactions as well as for Vivakor's existing operations.

About Vivakor, Inc.
Vivakor is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. More information can be found about Vivakor at www.vivakor.com.

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products, markets and business strategies. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
---------------------------------------------------------------------


OTCMarketbulls.com is an online financial destination where money managers, analysts, and individual investors can converge to discover new and exciting investment news, opportunities, and ideas. OTCMarketBulls.com is focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by OTCMarketBulls.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.

For full disclaimer/disclosure: http://www.otcmarketbulls.com/disclaimer.php

# # #

OTCMarketbulls.com is the internet’s preeminent penny stock destination; we research special situation stocks with high potential for price appreciation. To view some of our profiled stocks, please visit us today @ http://www.otcmarketbulls.com/OTCMBlandingpage.php